- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
300 results
2036 Exhibit: Latest paper from the father of CAR T CAR T really completely cured c...
Document
IPR2022-00855, No. 2036-82 Exhibit - Latest paper from the father of CAR T CAR T really completely cured cancer, MEDICALTRENDORG, httpsmedicaltrendorg20220203latest paper from the fa...
|
|
Cite Document
2021 Exhibit: Carl June Named One of Time���s 100 Most Influential People in the W...
Document
IPR2022-00855, No. 2021-67 Exhibit - Carl June Named One of Time���s 100 Most Influential People in the World, PENN MEDICINE Apr 26, 2018, httpspathologymedupennedunewscarl june nam...
|
|
Cite Document
2037 Exhibit: Bipulendu Jena et al, Redirecting T cell specificity by introducing a tum...
Document
IPR2022-00855, No. 2037-83 Exhibit - Bipulendu Jena et al, Redirecting T cell specificity by introducing a tumor specific chimeric antigen receptor, 116 BLOOD 1035 2010 (P.T.A.B. Jul. 19, 2022...
|
|
Cite Document
2019 Exhibit: Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen R...
Document
IPR2022-00855, No. 2019-65 Exhibit - Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen Receptor CAR Targeting CD 19 CTL0l 9 Produce Significant In Vivo Proliferation, Comp...
|
|
Cite Document
2040 Exhibit: ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ern...
Document
IPR2022-00855, No. 2040-86 Exhibit - ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ernest Beutler Lecture and Prize, SCIENCEX Aug 27, 2012, httpssciencexcomwire news1...
|
|
Cite Document
2007 Exhibit: FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE TH...
Document
IPR2022-00855, No. 2007-53 Exhibit - FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE THERAPY TO THE UNITED STATES Aug 30, 2017, httpswwwfdagovnews eventspress ...
|
|
Cite Document
2035 Exhibit: Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CA...
Document
IPR2022-00855, No. 2035-81 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHER...
|
|
Cite Document
2011 Exhibit: Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin ly...
Document
IPR2022-00855, No. 2011-57 Exhibit - Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20 spec...
|
|
Cite Document
2004 Exhibit: Gina Kolata, A Cancer Treatment Makes Leukemia Vanish, but Creat...
Document
IPR2022-00855, No. 2004-50 Exhibit - Gina Kolata, A Cancer Treatment Makes Leukemia Vanish, but Creates More Mysteries, NY TIMES Feb 2, 2022, httpswwwnytimescom20220202healthleuk...
|
|
Cite Document
2016 Exhibit: Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Imm...
Document
IPR2022-00855, No. 2016-62 Exhibit - Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Immunotherapy, 342 SCI 1432 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2025 Exhibit: Agilent Presents Thought Leader Award to Drs Carl H June and Micha...
Document
IPR2022-00855, No. 2025-71 Exhibit - Agilent Presents Thought Leader Award to Drs Carl H June and Michael Milone, AGILENT TECHS INC Nov 17, 2020, httpswwwagilentcomaboutnewsroomp...
|
|
Cite Document
2026 Exhibit: Information Disclosure Statement Initialed by Examiner Apr 18, 2016...
Document
IPR2022-00855, No. 2026-72 Exhibit - Information Disclosure Statement Initialed by Examiner Apr 18, 2016, US Patent Application No 14,997,136 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2001 Exhibit: Jason Fagone, Has Carl June Found a Key to Fighting Cancer, PHILA...
Document
IPR2022-00855, No. 2001-47 Exhibit - Jason Fagone, Has Carl June Found a Key to Fighting Cancer, PHILA MAG Aug 1, 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2017 Exhibit: David L Porter et al, Chimeric Antigen Receptor Modified T Cells Direc...
Document
IPR2022-00855, No. 2017-63 Exhibit - David L Porter et al, Chimeric Antigen Receptor Modified T Cells Directed Against CD 19 CTL0l 9 cells Have Long Term Persistence And Induce Durable Re...
|
|
Cite Document
2010 Exhibit: Barbara Savoldo et al, CD28 costimulation improves expansion and p...
Document
IPR2022-00855, No. 2010-56 Exhibit - Barbara Savoldo et al, CD28 costimulation improves expansion and persistence of chimeric antigen receptor modified T cells in lymphoma patients, 121 J C...
|
|
Cite Document
